文献速递性腺与生殖内分泌肥胖与代谢综合征

与多囊卵巢综合征女性和无多囊卵巢综合征女性代谢风险相关的新型脂质组学特征

Novel Lipidomic Signature Associated With Metabolic Risk in Women With and Without Polycystic Ovary Syndrome.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

该研究利用76名女性(42例多囊卵巢综合征)的既有数据和生物样本,通过质谱分析超过700种脂质,并与肥胖和胰岛素敏感性等代谢指标进行关联分析。研究发现,无论是否患多囊卵巢综合征,高LPI(18:0)和低含DHA脂质与更高的肥胖、胰岛素抵抗、空腹胰岛素、HbA1c和FAI以及更低的SHBG相关。作者指出需要前瞻性研究在更大队列中验证这些发现。

要点

  • 在多囊卵巢综合征女性和无多囊卵巢综合征女性中,LPI(18:0)与所测所有代谢风险因素关联最强。
  • 较高的LPI(18:0)和较低的含DHA脂质与更高的肥胖、胰岛素抵抗、空腹胰岛素、HbA1c和FAI以及更低的SHBG相关。
  • 这些关联独立于多囊卵巢综合征状态。

核心结论

  • 由高LPI(18:0)和低含DHA脂质组成的独特脂质组学特征与聚集于多囊卵巢综合征的关键代谢风险因素相关,且独立于多囊卵巢综合征状态。

研究设计与样本

  • 利用76名女性(其中42例多囊卵巢综合征)的既有数据和生物样本,通过质谱分析超过700种脂质。
  • 比较有无多囊卵巢综合征女性的脂质,并与直接测量的肥胖指标(双能X线吸收法和计算机断层扫描)和胰岛素敏感性(高胰岛素-正常血糖钳夹)以及空腹胰岛素、HbA1c和激素参数进行相关性分析。
  • 使用多变量线性回归并校正多重检验。

主要发现

  • 尽管未发现按多囊卵巢综合征状态分组的差异,但酯化有18:0脂肪酸的溶血磷脂酰肌醇(LPI)种类是与有无多囊卵巢综合征女性中所测所有代谢风险因素关联最强的脂质种类。
  • 在整个队列中,较高的LPI(18:0)浓度和较低的含二十二碳六烯酸(DHA,22:6)n-3多不饱和脂肪酸的脂质浓度与更高的肥胖、胰岛素抵抗、空腹胰岛素、HbA1c和FAI以及更低的SHBG相关。

局限性

  • 需要前瞻性研究在更大且多囊卵巢综合征表型各异的女性队列中验证这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Dyslipidemia is a feature of polycystic ovary syndrome (PCOS) and may augment metabolic dysfunction in this population. OBJECTIVE: Using comprehensive lipidomic profiling and gold-standard metabolic measures, we examined whether distinct lipid biomarkers were associated with metabolic risk in women with and without PCOS. METHODS: Using preexisting data and biobanked samples from 76 women (n = 42 with PCOS), we profiled > 700 lipid species by mass spectrometry. Lipids were compared between women with and without PCOS and correlated with direct measures of adiposity (dual x-ray absorptiometry and computed tomography) and insulin sensitivity (hyperinsulinemic-euglycemic clamp), as well as fasting insulin, HbA1c, and hormonal parameters (luteinizing and follicle-stimulating hormones; total and free testosterone; sex hormone-binding globulin [SHBG]; and free androgen index [FAI]). Multivariable linear regression was used with correction for multiple testing. RESULTS: Despite finding no differences by PCOS status, lysophosphatidylinositol (LPI) species esterified with an 18:0 fatty acid were the strongest lipid species associated with all the metabolic risk factors measured in women with and without PCOS. Across the cohort, higher concentrations of LPI(18:0) and lower concentrations of lipids containing docosahexaenoic acid (DHA, 22:6) n-3 polyunsaturated fatty acids were associated with higher adiposity, insulin resistance, fasting insulin, HbA1c and FAI, and lower SHBG. CONCLUSION: Our data indicate that a distinct lipidomic signature comprising high LPI(18:0) and low DHA-containing lipids are associated with key metabolic risk factors that cluster in PCOS, independent of PCOS status. Prospective studies are needed to corroborate these findings in larger cohorts of women with varying PCOS phenotypes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Mousa A, Huynh K, Ellery SJ, et al. Novel Lipidomic Signature Associated With Metabolic Risk in Women With and Without Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2022. PMID: 34971378. doi:10.1210/clinem/dgab931

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。